Reproductive outcomes after in vitro fertilization treatment in a cohort of Danish women transplanted with cryopreserved ovarian tissue.
Abortion, Spontaneous
/ etiology
Adolescent
Adult
Cancer Survivors
Cryopreservation
Denmark
Embryo Transfer
Female
Fertility Preservation
/ adverse effects
Fertilization in Vitro
Humans
Infertility, Female
/ diagnosis
Live Birth
Oocyte Retrieval
Ovarian Reserve
Ovary
/ physiopathology
Ovulation Induction
Pregnancy
Pregnancy Rate
Reproductive Techniques, Assisted
/ adverse effects
Retrospective Studies
Transplantation, Autologous
Treatment Outcome
Young Adult
Assisted reproductive technology
fertility preservation
ovarian tissue cryopreservation
ovarian tissue transplantation
reproductive outcome
Journal
Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
16
12
2019
revised:
22
03
2020
accepted:
25
03
2020
pubmed:
7
7
2020
medline:
20
4
2021
entrez:
7
7
2020
Statut:
ppublish
Résumé
To evaluate ovarian stimulation regimens and reproductive outcomes in a cohort of women undergoing ovarian tissue cryopreservation (OTC) and ovarian tissue transplantation (OTT). Retrospective cohort study. University hospital and fertility clinics. Twenty-eight women undergoing OTT and in vitro fertilization (IVF) from 2012 to 2017. OTC, OTT, and IVF. Ovarian stimulation and IVF outcomes. In total, 99 cycles were performed in 28 patients. In 19 patients responding to stimulation, a median of 3.0 cycles per patient (range: 1-14 cycles) was performed, and 2.0 mature oocytes were retrieved per cycle. The empty follicle rate was 35.9%. Eleven women achieved 15 pregnancies, of which 60% were lost during the first or second trimester, resulting in 5 of 28 women having ≥1 live births, and seven healthy children being born. In breast cancer patients (mean age at OTC: 33.0 years), the pregnancy rates (PR) and live birth rates (LBR) were 35.0% and 5.0% per embryo transfer, respectively. Patients aged ≥34.5 years at OTC all had breast cancer and did not achieve any pregnancies. For all other diagnoses (mean age at OTC: 26.6 years), PR and LBR were 50.0% and 37.5% per embryo transfer, respectively. Collectively, 39% of patients conceived at least once, and 17.9% delivered. Frozen-thawed embryo transfer (FET) resulted in more pregnancies than did fresh embryo transfer. Our results suggest that women of advanced maternal age undergoing OTC and IVF have a poor ovarian reserve, resulting in a poor reproductive outcome. Interestingly, FET appeared to be superior to fresh transfer.
Identifiants
pubmed: 32624219
pii: S0015-0282(20)30320-4
doi: 10.1016/j.fertnstert.2020.03.035
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
379-387Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.